当前位置:首页 - 行情中心 - 红日药业(300026) - 财务分析 - 现金流量表

红日药业

(300026)

  

流通市值:95.14亿  总市值:95.23亿
流通股本:30.01亿   总股本:30.04亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,625,008,824.751,258,058,257.465,715,513,731.454,462,596,762.16
  收到的税费返还7,426,960.413,868,638.0238,191,947.2634,027,369.71
  收到其他与经营活动有关的现金55,869,927.7133,364,931.2263,549,213.32104,610,751.55
  经营活动现金流入小计2,688,305,712.871,295,291,826.75,817,254,892.034,601,234,883.42
  购买商品、接受劳务支付的现金796,880,813.76417,972,809.681,831,632,871.121,554,725,075.47
  支付给职工以及为职工支付的现金452,173,023.82251,039,051.95875,668,988.54687,212,806.45
  支付的各项税费247,834,871.77130,197,089.28490,180,770.97368,304,475.51
  支付其他与经营活动有关的现金833,325,562.19404,704,418.471,808,430,650.611,454,155,889.5
  经营活动现金流出小计2,330,214,271.541,203,913,369.385,005,913,281.244,064,398,246.93
  经营活动产生的现金流量净额358,091,441.3391,378,457.32811,341,610.79536,836,636.49
二、投资活动产生的现金流量:
  收回投资收到的现金--661,091.33661,091.33
  处置固定资产、无形资产和其他长期资产收回的现金净额324,690.428,728.3703,899.49496,913.03
  处置子公司及其他营业单位收到的现金净额16,544,197.04---
  收到的其他与投资活动有关的现金--1,540,0001,540,000
  投资活动现金流入小计16,868,887.468,728.32,904,990.822,698,004.36
  购建固定资产、无形资产和其他长期资产支付的现金47,954,717.3628,836,828.69130,249,796.0396,062,756.25
  支付其他与投资活动有关的现金1.29---
  投资活动现金流出小计47,954,718.6528,836,828.69130,249,796.0396,062,756.25
  投资活动产生的现金流量净额-31,085,831.19-28,828,100.39-127,344,805.21-93,364,751.89
三、筹资活动产生的现金流量:
  取得借款收到的现金83,429,052.02794,748.8955,331,629.0551,259,969.06
  筹资活动现金流入小计83,429,052.02794,748.8955,331,629.0551,259,969.06
  偿还债务支付的现金224,053,881.3311,338,600352,520,132.77228,127,962.39
  分配股利、利润或偿付利息支付的现金8,706,417.875,995,789.4122,973,706.96110,281,541.99
  其中:子公司支付给少数股东的股利、利润3,136,0003,136,00017,575,913.218,752,313.21
  支付其他与筹资活动有关的现金22,285,798.2215,083,160.349,850,103.3342,608,799.67
  筹资活动现金流出小计255,046,097.4232,417,549.7525,343,943.06381,018,304.05
  筹资活动产生的现金流量净额-171,617,045.4-31,622,800.81-470,012,314.01-329,758,334.99
四、汇率变动对现金及现金等价物的影响-8,905,897.85-4,993,071.72-3,456,522.37-694,148.83
五、现金及现金等价物净增加额146,482,666.8925,934,484.4210,527,969.2113,019,400.78
  加:期初现金及现金等价物余额1,483,651,060.81,483,651,060.81,273,123,091.61,273,123,091.6
  期末现金及现金等价物余额1,630,133,727.691,509,585,545.21,483,651,060.81,386,142,492.38
补充资料:
  净利润82,910,766.17-22,223,495.61-
  资产减值准备26,146,896.21-238,528,350.71-
  固定资产和投资性房地产折旧120,613,685.85-247,900,563.9-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧120,613,685.85-247,900,563.9-
  无形资产摊销16,657,147.61-34,361,030.65-
  长期待摊费用摊销8,450,561.67-27,921,084.53-
  处置固定资产、无形资产和其他长期资产的损失-11,039.76--702,535.55-
  固定资产报废损失959,483.87-1,248,282.67-
  财务费用11,933,312.33-25,374,703.59-
  投资损失10,776,202.06-3,658,808.4-
  递延所得税-13,920,771.74--9,484,132.68-
  其中:递延所得税资产减少-11,955,389.75--1,238,114.57-
    递延所得税负债增加-1,965,381.99--8,246,018.11-
  存货的减少-7,185,876.56-255,248,103.48-
  经营性应收项目的减少68,521,884.76-252,022,267.38-
  经营性应付项目的增加9,026,890.64--329,863,767.03-
  其他-5,641,927.24--6,021,944.1-
  现金的期末余额1,630,133,727.69-1,483,651,060.8-
  减:现金的期初余额1,483,651,060.8-1,273,123,091.6-
  现金及现金等价物的净增加额146,482,666.89-210,527,969.2-
公告日期2026-08-262026-04-292026-04-212025-10-29
审计意见(境内)标准无保留意见
TOP↑